MabDesign SUP’Biotech
Co-organisé par MabDesign et SUP’Biotech


Pitch Innovation


Primary Cell Bioassays to quantify antibody drug potency in antibody-dependent cellular cytotoxicity (ADCC).

Promega primary cell bioassays provide a convenient bioluminescent detection method for target cell killing. These assays are biologically relevant, MOA-based assays that can be used to measure the potency and stability of antibodies and other biologics that specifically bind and activate Fcγ receptors. The assays include ADCC-qualified Primary peripheral blood mononuclear cells (PBMCs) and a choice of target cells stably expressing HiBiT fusion proteins. Upon lysis of the target cells and addition of detection reagent, a bright bioluminescent signal is generated. PBMC ADCC Bioassay (promega.com)

Stemcell Technologies

Organoid culture: a breakthrough

Stemcell Technologies At STEMCELL, science is our foundation. Driven by our mission to advance research globally, we offer over 2,500 tools and services supporting scientists working in stem cell research, regenerative medicine, immunotherapy, and disease research. Organoids and organotypic model systems are powerful new tools for research approaches in modeling and understanding human health and disease. STEMCELL Technologies supports organoid researchers with high-quality cell culture media and kits that enable robust establishment, expansion, maintenance, and differentiation of organoid cultures. To explore STEMCELL's high-quality organoid media and differentiation kits, visit: www.stemcell.com/organoid-products.
Organoid Products